Please assess the completion status of the following clinical trial:

Trial Title: AVJ Ablation Followed by Resynchronization Therapy in Patients With CHF and AF

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic permanent AF~* Class I or II indication for ICD~* LVEF ≤ 35% within 6 months~* NYHA class II or III with a history of CHF~* Maximal tolerated drug therapy for CHF and rate control with a stable regimen for ≥ 30 days~* Ability to independently comprehend and complete a QoL questionnaire~* Ability to give informed consent for study participation and willingness and ability to comply with prescribed follow-up tests and scheduled evaluations~Exclusion Criteria:~* Paroxysmal or persistent AF~* Class I indication for pacing (including AVJ ablation for poor rate control)~* Ability to walk ≥ 450 meters in 6 minutes~* Musculoskeletal disorders that prohibit the completion of a 450 meters walk~* NYHA class I or IV at the time of enrollment~* A contraindication to taking Coumadin therapy~* History of myocardial infarction, percutanous coronary intervention, or CABG in the past 30 days~* History of mitral valve surgery~* Prior attempts for cardiac resynchronization therapy~* The presence of an existing coronary sinus lead or epicardial lead~* Life expectancy \< 1year~* Age \< 18 yrs~* Current participation in other clinical studies except registry trials~* Use of calcium channel blockers~* Pregnancy~* Inability to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CRT-D + AVJ Ablation (Type: None): None
- Single-Chamber ICD + Pharmacological Therapy (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).